User banner image
User avatar
  • admin

Posts

Disclosure of total number of voting rights and number of shares in the capital at December 31, 2024

French limited company (Société anonyme) with registered capital of 106,862,389.20 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure...

[Latest] Global Sustainable Tourism Market Size/Share Worth USD 13 Trillion by 2033 at a 13.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Sustainable Tourism Market size &...

SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors

KING OF PRUSSIA, Pa., Jan. 28, 2025 (GLOBE NEWSWIRE) — SEED Therapeutics Inc. (“SEED”), a biotechnology company pioneering the discovery of molecular glues for targeted...

BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies

FLORHAM PARK, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company developing innovative cancer...

Walden Biosciences Appoints Howard Mayer, M.D. to Board of Directors

Veteran Leader Brings Extensive Expertise in Rare Disease, including Renal Disease, and a Track Record of Regulatory Success with Orphan Diseases and Breakthrough Therapy Designations...

SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142

SAB-142 was generally well-tolerated among healthy volunteers; data from Phase 1 trial confirms SAB-142 does not cause serum sickness or anti-drug antibodies at target dose...

atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder

– A single dose of BPL-003, combined with relapse prevention therapy, produced meaningful and sustained reductions in alcohol use, with 50% of patients maintaining complete...

Mastery Made Easy – HIKMICRO Packs Next Generation Thermal Technology into One Hand with New FALCON 2.0 & CONDOR LRF 2.0

HANGZHOU, China, Jan. 28, 2025 /PRNewswire/ — Pioneering optics manufacturer HIKMICRO set a new standard for thermal hunting with the launch of the FALCON 2.0 and...

Mercari Launches New Marketplace Mercari NFT

Mercari Users Can Now Use Mercari to Buy and Sell Popular NFTs Listed on OpenSea TOKYO, Jan. 28, 2025 /PRNewswire/ — Mercari, Inc. (“Mercari”) announces that...

Enfinity Global Secures 2 GW of Connectivity for Solar and Wind Projects in India

HYDERABAD, India, Jan. 28, 2025 /PRNewswire/ — Enfinity Global, a global leader in renewable energy, has secured connectivity for 2 GW of utility-scale solar PV and...